Your browser doesn't support javascript.
loading
Effects of BA.1/BA.2 subvariant, vaccination, and prior infection on infectiousness of SARS-CoV-2 Omicron infections
Suelen H. Qassim; Hiam Chemaitelly; Houssein Ayoub; Sawsan AlMukdad; Patrick Tang; Mohammad R. Hasan; HADI M. YASSINE; Hebah A. Al-Khatib; Maria K. Smatti; Hanan F. Abdul Rahim; Gheyath Nasrallah; Mohamed Ghaith Al-Kuwari; Abdullatif Al Khal; Peter Coyle; Anvar Hassan Kaleeckal; Riyazuddin Mohammad Shaik; Ali Nizar Latif; Einas Al-Kuwari; Andrew Jeremijenko; Adeel A Butt; Roberto Bertollini; Hamad Eid Al Romaihi; Mohamed H. Al-Thani; Laith J Abu-Raddad.
Afiliación
  • Suelen H. Qassim; Weill Cornell Medicine-Qatar
  • Hiam Chemaitelly; Weill Cornell Medicine-Qatar
  • Houssein Ayoub; Qatar University
  • Sawsan AlMukdad; Weill Cornell Medicine-Qatar
  • Patrick Tang; Sidra Medicine
  • Mohammad R. Hasan; Sidra Medicine
  • HADI M. YASSINE; Qatar University
  • Hebah A. Al-Khatib; Qatar University
  • Maria K. Smatti; Qatar University
  • Hanan F. Abdul Rahim; Qatar University
  • Gheyath Nasrallah; Qatar University
  • Mohamed Ghaith Al-Kuwari; Primary Health Care Corporation
  • Abdullatif Al Khal; Hamad Medical Corporation
  • Peter Coyle; Hamad Medical Corporation
  • Anvar Hassan Kaleeckal; Hamad Medical Corporation
  • Riyazuddin Mohammad Shaik; Hamad Medical Corporation
  • Ali Nizar Latif; Hamad Medical Corporation
  • Einas Al-Kuwari; Hamad Medical Corporation
  • Andrew Jeremijenko; Hamad Medical Corporation
  • Adeel A Butt; Hamad Medical Corporation
  • Roberto Bertollini; Ministry of Public Health
  • Hamad Eid Al Romaihi; Ministry of Public Health
  • Mohamed H. Al-Thani; Ministry of Public Health
  • Laith J Abu-Raddad; Weill Cornell Medicine-Qatar
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-22271771
ABSTRACT
BACKGROUNDQatar experienced a large SARS-CoV-2 Omicron (B.1.1.529) wave that started on December 19, 2021 and peaked in mid-January, 2022. We investigated effects of Omicron subvariant (BA.1 and BA.2), previous vaccination, and prior infection on infectiousness of Omicron infections, between December 23, 2021 and February 20, 2022. METHODSUnivariable and multivariable regression analyses were conducted to estimate the association between the RT-qPCR cycle threshold (Ct) value of PCR tests (a proxy for SARS-CoV-2 infectiousness) and each of the Omicron subvariants, mRNA vaccination, prior infection, reason for RT-qPCR testing, calendar week of RT-qPCR testing (to account for phases of the rapidly evolving Omicron wave), and demographic factors. RESULTSCompared to BA.1, BA.2 was associated with 3.53 fewer cycles (95% CI 3.46-3.60), signifying higher infectiousness. Ct value decreased with time since second and third vaccinations. Ct values were highest for those who received their boosters in the month preceding the RT-qPCR test--0.86 cycles (95% CI 0.72-1.00) higher than for unvaccinated persons. Ct value was 1.30 (95% CI 1.20-1.39) cycles higher for those with a prior infection compared to those without prior infection, signifying lower infectiousness. Ct value declined gradually with age. Ct value was lowest for those who were tested because of symptoms and was highest for those who were tested for travel-related purposes. Ct value was lowest during the exponential-growth phase of the Omicron wave and was highest after the wave peaked and was declining. CONCLUSIONSThe BA.2 subvariant appears substantially more infectious than the BA.1 subvariant. This may reflect higher viral load and/or longer duration of infection, thereby explaining the rapid expansion of this subvariant in Qatar.
Licencia
cc_no
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Experimental_studies Idioma: En Año: 2022 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Experimental_studies Idioma: En Año: 2022 Tipo del documento: Preprint